ecNumber*3.4.23.16#turnoverNumber*0.0008#turnoverNumberMaximum*#substrate*AETFYVDGAA#commentary*pH 5.6, 37&deg;C, autolysis reistant and truncated enzyme form PR-(5-99) with mutation Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*17002#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.000833#turnoverNumberMaximum*#substrate*REYDQILIKVS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17090#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.001#turnoverNumberMaximum*#substrate*REYDQILIKVS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17090#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.018#turnoverNumberMaximum*#substrate*TATIMMQRGN#commentary*pH 5.0, 37&deg;C, mutant enzyme A28S#organism*Human immunodeficiency virus 1#ligandStructureId*11333#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*0.018#turnoverNumberMaximum*#substrate*TATIMMQRGN#commentary*pH 5.0, 37&deg;C, mutant enzyme A28S#organism*Human immunodeficiency virus 1#ligandStructureId*11333#literature*648171#!ecNumber*3.4.23.16#turnoverNumber*0.025#turnoverNumberMaximum*#substrate*REYDQIIIEVS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17088#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.026#turnoverNumberMaximum*#substrate*RQGTVSFNFPQITL#commentary*pH 5.0, 37&deg;C, mutant enzyme A28S#organism*Human immunodeficiency virus 1#ligandStructureId*6802#literature*648171#!ecNumber*3.4.23.16#turnoverNumber*0.0267#turnoverNumberMaximum*#substrate*REYDQIIIEVS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17088#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.04#turnoverNumberMaximum*#substrate*DTVIEEMS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17024#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.0483#turnoverNumberMaximum*#substrate*DTVIEEMS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17024#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.05#turnoverNumberMaximum*#substrate*CTLNFPISP#commentary*pH 5.6, 37&deg;C, autolysis reistant and truncated enzyme form PR-(5-99) with mutation Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*8496#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.06#turnoverNumberMaximum*#substrate*VLQNYPIVQ#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*5743#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.0667#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.08#turnoverNumberMaximum*#substrate*IRKILFLDG#commentary*pH 5.6, 37&deg;C, autolysis reistant and truncated enzyme form PR-(5-99) with mutation Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*11260#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.08#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*0.0833#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.0967#turnoverNumberMaximum*#substrate*PQITLWQRP#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*22355#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.103#turnoverNumberMaximum*#substrate*PQITLWQRP#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*22355#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.11#turnoverNumberMaximum*#substrate*KARVLAEAMS#commentary*pH 5.6, 37&deg;C, autolysis reistant and truncated enzyme form PR-(5-99) with mutation Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*11302#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.125#turnoverNumberMaximum*#substrate*DTVVEEMS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17026#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.13#turnoverNumberMaximum*#substrate*DTVVEEMS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17026#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*0.133#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.16#turnoverNumberMaximum*#substrate*VVQNYPIVQ#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*6804#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.167#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.172#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme V82E#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*0.18#turnoverNumberMaximum*#substrate*VVQNYPIVQ#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*6804#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.183#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.2#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.25#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.26#turnoverNumberMaximum*#substrate*VLQNYPIVQ#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*5743#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.267#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.3#turnoverNumberMaximum*#substrate*IPFAAAQQRK#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*11712#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.3#turnoverNumberMaximum*#substrate*KARLMAEALK#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*12196#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.317#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.333#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.367#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.4#turnoverNumberMaximum*#substrate*VSQLYPIVQ#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*4965#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.41#turnoverNumberMaximum*#substrate*AETFYVDGAA#commentary*pH 5.6, 37&deg;C, autolysis resistant enzyme form PR with the mutations Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*17002#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.44#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, truncated version PR-(5-99) from mutant enzyme Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648169#!ecNumber*3.4.23.16#turnoverNumber*0.467#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.467#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.5#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.533#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.583#turnoverNumberMaximum*#substrate*PAFVLAEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*6194#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.583#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.6#turnoverNumberMaximum*#substrate*KARLMAEALK#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*12196#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*0.6#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.6#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.617#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.633#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme V32I#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.717#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.75#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.767#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle#commentary*pH 5.0, mutant enzyme Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*17037#literature*648153#!ecNumber*3.4.23.16#turnoverNumber*0.833#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.89#turnoverNumberMaximum*#substrate*KARVLAEAMS#commentary*pH 5.6, 37&deg;C, autolysis resistant enzyme form PR with the mutations Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*11302#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*0.9#turnoverNumberMaximum*#substrate*PARVLAEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4674#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*0.933#turnoverNumberMaximum*#substrate*PAFVLMEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*52809#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.02#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.03#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.03#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.07#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.07#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.1#turnoverNumberMaximum*#substrate*Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg#commentary*mutant I50V, pH 5.6, 26&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*160791#literature*699546#!ecNumber*3.4.23.16#turnoverNumber*1.1#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.15#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.17#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.2#turnoverNumberMaximum*#substrate*IPFAAAQQRK#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*11712#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*1.2#turnoverNumberMaximum*#substrate*IRKILFLDG#commentary*pH 5.6, 37&deg;C, autolysis resistant enzyme form PR with the mutations Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*11260#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*1.22#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.23#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle#commentary*pH 5.0, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17037#literature*648153#!ecNumber*3.4.23.16#turnoverNumber*1.23#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme R8K#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.28#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.3#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.32#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.57#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.6#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.6#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme V82T/I84V#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.72#turnoverNumberMaximum*#substrate*CTLNFPISP#commentary*pH 5.6, 37&deg;C, autolysis resistant enzyme form PR with the mutations Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*8496#literature*648164#!ecNumber*3.4.23.16#turnoverNumber*1.73#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.82#turnoverNumberMaximum*#substrate*PARVLIEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4963#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.87#turnoverNumberMaximum*#substrate*PARVLMEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*6195#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*1.9#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648159#!ecNumber*3.4.23.16#turnoverNumber*2#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme V82T#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*2.02#turnoverNumberMaximum*#substrate*PARVLVEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4964#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*2.2#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*2.2#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme G48V/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*2.22#turnoverNumberMaximum*#substrate*PARVLLEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*5348#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*2.23#turnoverNumberMaximum*#substrate*Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg#commentary*mutant I54V, pH 5.6, 26&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*160791#literature*699546#!ecNumber*3.4.23.16#turnoverNumber*2.55#turnoverNumberMaximum*#substrate*PARVLFEAMR#commentary*mutant enzyme I84V#organism*Human immunodeficiency virus 1#ligandStructureId*4962#literature*648138#!ecNumber*3.4.23.16#turnoverNumber*2.6#turnoverNumberMaximum*#substrate*VSQVYPIVQ#commentary*wild type enzyme, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*5753#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*2.85#turnoverNumberMaximum*#substrate*REYDQILIEVS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17089#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*3#turnoverNumberMaximum*#substrate*VSQVYPIVQ#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*5753#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*3.07#turnoverNumberMaximum*#substrate*REYDQILIEVS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17089#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*3.14#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme L90M#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*3.14#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme L90M#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*3.2#turnoverNumberMaximum*#substrate*Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg#commentary*wild-type, pH 5.6, 26&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*160791#literature*699546#!ecNumber*3.4.23.16#turnoverNumber*3.2#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease D30N/N88D#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*3.5#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, mutant enzyme C67A/C95A and mutant enzyme C95A#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648159#!ecNumber*3.4.23.16#turnoverNumber*3.5#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant D30M/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*3.67#turnoverNumberMaximum*#substrate*Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg#commentary*mutant G48V, pH 5.6, 26&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*160791#literature*699546#!ecNumber*3.4.23.16#turnoverNumber*3.7#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, mutant enzyme C67A#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648159#!ecNumber*3.4.23.16#turnoverNumber*3.74#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648169#!ecNumber*3.4.23.16#turnoverNumber*4#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease D30N/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*4.02#turnoverNumberMaximum*#substrate*VSQNYPIV#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*11336#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*4.14#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-ER#commentary*pH 5.2, 2.0 M NaCl#organism*Human immunodeficiency virus 1#ligandStructureId*16975#literature*648156#!ecNumber*3.4.23.16#turnoverNumber*4.3#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant N88D#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*4.32#turnoverNumberMaximum*#substrate*VSQNYPIV#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*11336#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*4.35#turnoverNumberMaximum*#substrate*DTVLEEMS#commentary*pH 5.5, 30&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17025#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*4.58#turnoverNumberMaximum*#substrate*DTVLEEMS#commentary*pH 5.5, 30&deg;C, mutant enzyme Q7K/L33I/L63I#organism*Human immunodeficiency virus 1#ligandStructureId*17025#literature*648136#!ecNumber*3.4.23.16#turnoverNumber*4.8#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*5#turnoverNumberMaximum*#substrate*Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg#commentary*mutant I54M, pH 5.6, 26&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*160791#literature*699546#!ecNumber*3.4.23.16#turnoverNumber*5#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant D30N#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*5.05#turnoverNumberMaximum*#substrate*GAETFYVDGAA#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*33426#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*5.1#turnoverNumberMaximum*#substrate*VSQLYPIVQ#commentary*mutant enzyme V32I/I47V/V82I, in 0.5 M potassium phosphate buffer, pH 5.6, containing 10% (v/v) glycerol, 2 mM EDTA, 10 mM dithiothreitol, 4 M NaCl, at 37&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*4965#literature*718370#!ecNumber*3.4.23.16#turnoverNumber*5.2#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, mutant enzyme Q7K/R8Q/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648169#!ecNumber*3.4.23.16#turnoverNumber*5.46#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-ER#commentary*pH 4.5, 0.1 M NaCl#organism*Human immunodeficiency virus 1#ligandStructureId*16975#literature*648156#!ecNumber*3.4.23.16#turnoverNumber*5.5#turnoverNumberMaximum*#substrate*KARV-Nle-Phe(NO2)-EA-Nle-NH2#commentary*pH 5.0, 25&deg;C, mutant enzyme Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*4672#literature*648169#!ecNumber*3.4.23.16#turnoverNumber*5.6#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype C protease#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*5.8#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-QR#commentary*pH 4.8, 0.1 M NaCl#organism*Human immunodeficiency virus 1#ligandStructureId*11276#literature*648156#!ecNumber*3.4.23.16#turnoverNumber*5.8#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*7.4#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-QR-NH2#commentary*pH 6.0, 25&deg;C#organism*Human immunodeficiency virus 1#ligandStructureId*33296#literature*648151#!ecNumber*3.4.23.16#turnoverNumber*8#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme N88D#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*9.25#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-QR#commentary*pH 4.9, 1.0 M NaCl#organism*Human immunodeficiency virus 1#ligandStructureId*11276#literature*648156#!ecNumber*3.4.23.16#turnoverNumber*9.7#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme I82V#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*10#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*10.2#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease N88D/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*12#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant N88D; 37&deg;C, pH 4.7, HIV-1 subtype C protease mutant D30N#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*12#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme A71V#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*12.4#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease mutant D30N/N88D#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*12.7#turnoverNumberMaximum*#substrate*KLRPGNFLQSRP#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17039#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*12.7#turnoverNumberMaximum*#substrate*KLRPGNFLQSRP#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*17039#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*13#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-Gly#commentary*37&deg;C, pH 4.7, HIV-1 subtype B protease N88D/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*2621#literature*678346#!ecNumber*3.4.23.16#turnoverNumber*14#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme D30N/A71V#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*16#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme D30N/L63PA71V/L90M; 37&deg;C, pH 4.7, mutant enzyme L90M#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*17#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme D30N#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*19.2#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme A28S#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*19.5#turnoverNumberMaximum*#substrate*2-aminobenzoyl-TI-Nle-Phe(NO2)-QR#commentary*pH 5.0, 2.0 M NaCl#organism*Human immunodeficiency virus 1#ligandStructureId*11276#literature*648156#!ecNumber*3.4.23.16#turnoverNumber*20.7#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme V82A#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*22#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme D30N/L90M#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*24#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, mutant enzyme D30N/N88D#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*30#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-Phe(4-NO2)-Glu-Ala-Nle-NH2#commentary*37&deg;C, pH 4.7, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*3937#literature*681460#!ecNumber*3.4.23.16#turnoverNumber*30.9#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme V82E#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*31.3#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme G48V#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*31.3#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme G48V#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*51.8#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*51.8#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*58.8#turnoverNumberMaximum*#substrate*TATIMMQRGN#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*11333#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*58.8#turnoverNumberMaximum*#substrate*TATIMMQRGN#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*11333#literature*648171#!ecNumber*3.4.23.16#turnoverNumber*61#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, 25&deg;C, mutant L24I#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666063#!ecNumber*3.4.23.16#turnoverNumber*62.7#turnoverNumberMaximum*#substrate*RQGTVSFNFPQITL#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*6802#literature*648142#!ecNumber*3.4.23.16#turnoverNumber*62.7#turnoverNumberMaximum*#substrate*RQGTVSFNFPQITL#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*6802#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*62.7#turnoverNumberMaximum*#substrate*RQGTVSFNFPQITL#commentary*pH 5.0, 37&deg;C, wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*6802#literature*648171#!ecNumber*3.4.23.16#turnoverNumber*93.5#turnoverNumberMaximum*#substrate*VSQNYPIVQ#commentary*pH 5.0, 37&deg;C, mutant enzyme G48H#organism*Human immunodeficiency virus 1#ligandStructureId*1312#literature*648148#!ecNumber*3.4.23.16#turnoverNumber*194.5#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, mutant V82A#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666016#!ecNumber*3.4.23.16#turnoverNumber*280#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, 25&deg;C, mutant G73S#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666063#!ecNumber*3.4.23.16#turnoverNumber*285#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, mutant Q7K/L33I/L63I/C67A/C95A#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666016#!ecNumber*3.4.23.16#turnoverNumber*480#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, 25&deg;C, mutant I50V#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666063#!ecNumber*3.4.23.16#turnoverNumber*780#turnoverNumberMaximum*#substrate*Lys-Ala-Arg-Val-Nle-4-nitro-Phe-Glu-Ala-Nle-amide#commentary*pH 5.0, mutant I84V#organism*Human immunodeficiency virus 1#ligandStructureId*5800#literature*666016#